Advanced Biomedical Research

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 11  |  Issue : 1  |  Page : 44-

Comparing the effect of ondansetron–dexamethasone and metoclopramide–dexamethasone on postoperative nausea and vomiting after gynecological laparoscopy: A randomized double-blind clinical trial


Arvin Barzanji1, Karim Nasseri2, Shahram Sadeghi3, Mahsa Ardalan4, Bijan Nouri5, Khadijeh Daseh6 
1 Department of Anesthesiology, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran
2 Department of Anesthesiology, Faculty of Medicine, Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 Spiritual Health Research Center, Health Development Research Institute, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 Kurdistan University of Medical Sciences, Sanandaj, Iran
5 Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
6 Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran

Correspondence Address:
Mrs. Khadijeh Daseh
Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Pasdaran Blvd, Sanandaj
Iran

Background: Nausea and vomiting is a common complication after gynecological surgeries, especially laparoscopy, which can lead to discomfort and restlessness in the patients. The aim of the study was to compare the effect of ondansetron–dexamethasone and metoclopramide–dexamethasone on postoperative nausea and vomiting following gynecological laparoscopy. Materials and Methods: In this double-blind clinical trial, 68 females scheduled for gynecological laparoscopy and age range of 18–40 years were randomly divided into two groups. Group OD received ondansetron 4 mg plus dexamethasone 8 mg and group MD received metoclopramide 10 mg plus dexamethasone 8 mg, 15 min before the end of surgery. The incidence of nausea and vomiting and need for rescue medication was assessed during the recovery period, as well as at 2, 4, 6, 12, and 24 h after surgery. The data were analyzed using STATA software version 12 and a significance level of <0.05 was considered in this research. Results: The incidence of nausea in ondansetron and metoclopramide groups was 23.3% and 33.3%, respectively, and the frequency of vomiting was 10% and 16.6%, respectively, which showed no significant difference (P > 0.05). The highest incidence of nausea and vomiting in patients belonged to the metoclopramide group inside 4–6 h after surgery. Conclusion: Our study showed that no significant difference was observed in the incidence of nausea and vomiting between ondansetron–dexamethasone and metoclopramide–dexamethasone groups following laparoscopic gynecological surgery; however, the number of patients with nausea and vomiting was lower in the ondansetron–dexamethasone group.


How to cite this article:
Barzanji A, Nasseri K, Sadeghi S, Ardalan M, Nouri B, Daseh K. Comparing the effect of ondansetron–dexamethasone and metoclopramide–dexamethasone on postoperative nausea and vomiting after gynecological laparoscopy: A randomized double-blind clinical trial.Adv Biomed Res 2022;11:44-44


How to cite this URL:
Barzanji A, Nasseri K, Sadeghi S, Ardalan M, Nouri B, Daseh K. Comparing the effect of ondansetron–dexamethasone and metoclopramide–dexamethasone on postoperative nausea and vomiting after gynecological laparoscopy: A randomized double-blind clinical trial. Adv Biomed Res [serial online] 2022 [cited 2022 Jun 28 ];11:44-44
Available from: https://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=44;epage=44;aulast=Barzanji;type=0